| For: | Yang L, Xiao YY, Shao L, Ouyang CS, Hu Y, Li B, Lei LF, Wang H. Proprotein convertase subtilisin/kexin type 9 inhibitor non responses in an adult with a history of coronary revascularization: A case report. World J Clin Cases 2022; 10(19): 6728-6735 [PMID: 35979295 DOI: 10.12998/wjcc.v10.i19.6728] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i19/6728.htm |
| Number | Citing Articles |
| 1 |
Alfredo Mauriello, Aldo De Falco, Adriana Correra, Antonello D’Andrea, Francesco Giallauria, Antonio Giordano, Vincenzo Russo. Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives. Current Atherosclerosis Reports 2026; 28(1) doi: 10.1007/s11883-026-01414-2
|
| 2 |
|
| 3 |
Yuanjia Shi, Jing Zhang, Lina Dai, Jie Chen, Shijia Geng, Yan Niu, Chongyang Dong, Chenlei Li, Rujin Liu, Ningxia Zhao, Xiaomeng Wang, Zhanfeng Gao, Xi Yang, Shang Gao. PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway. Frontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1836294
|
| 4 |
Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, Luigi Falco, Alfredo Caturano, Antonello D’Andrea, Vincenzo Russo. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk. Genes 2023; 14(11) doi: 10.3390/genes14112057
|